dihexa pnb-0408 (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted Vincent Pedre, MD FMCP b12inj Treatment:3 Months

dihexa pnb-0408 (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted Vincent Pedre, MD FMCP b12inj Treatment:3 Months

Vincent Pedre, MD FMCP | Science is evolving, and that's worth paying attention to. Recently, an FDA advisory panel voted to recommend that BPC- 157 be added to the... | Instagram

BPC-157 has small uncontrolled reports and a recruiting Phase 2 trial without results

b12inj

Treatment:3 Months

Immunomodulatory and DNA-repairing properties can reduce inflammation and heal the gut